Companies › ENOV

ENOVIS CORPORATION COM (ENOV)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001420800 · EDGAR filings · Updated 2026-07-28

ENOVIS CORPORATION COM (ENOV) has reported institutional ownership of 116.5%, with 254 institutional managers holding positions valued at $1.53B per the latest 13F reporting period.

Filings this week (1)

• 2026-07-28 — SCHEDULE 13G/A filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-08 — SCHEDULE 13G/A filed
• 2026-07-01 — Insider transaction reported (Form 4)
• 2026-06-26 — 11-K filed
• 2026-06-16 — Insider transaction reported (Form 4)
• 2026-06-16 — 4/A filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ENOVIS CORPORATION COM has 254 institutional holders and institutional ownership of 116.5%.

Insider activity

Insiders reported 65 transactions (13 buys, 4 sells) across 18 reporting insiders, with a net reported value of $839.2K.

Related companies

HARMONY BIOSCIENCES HLDGS IN (HRMY) · ANAPTYSBIO INC (ANAB) · MAZE THERAPEUTICS INC (MAZE) · ESTABLISHMENT LABS HLDGS INC (ESTA) · OLEMA PHARMACEUTICALS INC (OLMA) · PACS GROUP (PACS)